Joyce Davidson
Overview
Explore the profile of Joyce Davidson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
506
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giani T, Smith E, Al-Abadi E, Armon K, Bailey K, Ciurtin C, et al.
Lupus
. 2021 Oct;
30(12):1955-1965.
PMID: 34601989
Introduction: Juvenile-onset systemic lupus erythematosus (JSLE) is a rare autoimmune/inflammatory disease with significant morbidity and mortality. Neuropsychiatric (NP) involvement is a severe complication, encompassing a heterogeneous range of neurological and...
2.
Massias J, Smith E, Al-Abadi E, Armon K, Bailey K, Ciurtin C, et al.
Lupus
. 2021 Jan;
30(4):597-607.
PMID: 33413005
Systemic lupus erythematosus (SLE) is a systemic autoimmune/inflammatory disease. Patients diagnosed with juvenile-onset SLE (jSLE), when compared to individuals with adult-onset SLE, develop more severe organ involvement, increased disease activity...
3.
Moreton R, Fleck B, Davidson J, Hughes D
BMJ Case Rep
. 2020 Feb;
13(2).
PMID: 32071125
A 9-year-old girl presented to hospital with a 6-week history of non-specific constitutional symptoms and weight loss. She initially underwent extensive medical investigation without diagnosis being achieved. Although raised inflammatory...
4.
Rooney M, Bishop N, Davidson J, Beresford M, Pilkington C, Donagh J, et al.
EClinicalMedicine
. 2019 Aug;
12:79-87.
PMID: 31388666
Background: Children and young people (CYP) with chronic rheumatic conditions; Juvenile Idiopathic Arthritis, Juvenile Systemic Lupus Erythematosus, Juvenile Dermatomyositis and Juvenile Vasculitis, treated with steroids, have low bone density, increased...
5.
Shoop-Worrall S, Hyrich K, Verstappen S, Sergeant J, Baildam E, Chieng A, et al.
Arthritis Care Res (Hoboken)
. 2019 Mar;
72(4):517-524.
PMID: 30875458
Objective: In pediatric research, investigators rely on proxy reports of outcome, such as the proxy-completed Childhood Health Assessment Questionnaire (C-HAQ), to assess function in juvenile idiopathic arthritis (JIA). As children...
6.
Surana S, Kumar R, Pitt M, Hafner P, McLellan A, Davidson J, et al.
Dev Med Child Neurol
. 2019 Feb;
61(11):1344-1347.
PMID: 30724344
Acquired neuromyotonia is a form of peripheral nerve hyperexcitability. In adults, pathogenic antibodies that target the extracellular domains of leucine-rich glioma-inactivated protein 1 (LGI1) and contactin-associated protein-like 2 (CASPR2) have...
7.
Hendry G, Shoop-Worrall S, Riskowski J, Andrews P, Baildam E, Chieng A, et al.
Rheumatol Adv Pract
. 2019 Jan;
2(2):rky039.
PMID: 30627693
Objective: The aim was to investigate the time course of lower limb disease activity and walking disability in children with JIA over a 5-year course. Methods: The Childhood Arthritis Prospective...
8.
Hanns L, Cordingley L, Galloway J, Norton S, Carvalho L, Christie D, et al.
Rheumatology (Oxford)
. 2018 Apr;
57(8):1381-1389.
PMID: 29697850
Objectives: To determine if depressive symptoms assessed near diagnosis associate with future measures of pain, disability and disease for adolescent patients diagnosed with JIA. Methods: Data were analysed from JIA...
9.
Shoop-Worrall S, Verstappen S, McDonagh J, Baildam E, Chieng A, Davidson J, et al.
Arthritis Rheumatol
. 2018 Apr;
70(9):1519-1529.
PMID: 29648683
Objective: Potential targets for treat-to-target strategies in juvenile idiopathic arthritis are minimal disease activity (MDA) and clinically inactive disease (CID). We undertook this study to compare short- and long-term outcomes...
10.
Martin N, Davidson J, Anderson C, Consolaro A, Bovis F, Ruperto N
Rheumatol Int
. 2018 Apr;
38(Suppl 1):67-73.
PMID: 29637357
The Juvenile Arthritis Multidimensional Assessment Report (JAMAR) is a new parent/patient-reported outcome measure that enables a thorough assessment of the disease status in children with juvenile idiopathic arthritis (JIA). We...